Dashboard
Manage Tickers

KVUEKenvue Inc.

NYSE www.jnj.com/kenvue/


$ 23.40 $ -0.01 (-0.04 %)    

Monday, 16-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 23.38
$ 23.39 x 2,600
$ 23.40 x 3,300
-- - --
$ 17.29 - $ 23.55
9,220,846
na
44.78B
$ 0.66
$ 40.01
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-01-2024 12-31-2023 10-K
4 11-03-2023 10-01-2023 10-Q
5 08-02-2023 07-02-2023 10-Q
6 06-02-2023 04-02-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

kenvue-set-to-pop-like-a-tylenol-gelcap-golden-cross-looms-on-stock-chart
Kenvue Set To Pop Like A Tylenol Gelcap? G...
09/10/2024 12:48:40

Kenvue Inc., owner of major brands like Tylenol, is poised for a technical knockout with a Golden Cross pattern and legal win.

magnificent-7-miss-out-2-cybersecurity-stocks-stand-firm-retailers-lag-in-volatile-august-here-are-the-top-sp-500-gainers-and-losers
Magnificent 7 Miss Out, 2 Cybersecurity St...
08/31/2024 19:55:31

The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.

johnson--johnson-spin-off-kenvue-wins-lawsuit-over-pain-killer-tylenol-rapid-release-gelcaps
Johnson & Johnson-Spin Off Kenvue Wins Law...
08/30/2024 17:47:55

Kenvue defends against a consumer lawsuit alleging that its Tylenol "Rapid Release" gelcaps did not relieve pain faster...

shopify-palantir-and-uber-are-among-top-10-large-cap-gainers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio
Shopify, Palantir And Uber Are Among Top 1...
08/11/2024 15:07:41

Top 10 best performing large-cap stocks last week: Shopify, Palantir, Axon, Fortinet, Trade Desk, Natera, SharkNinja, Zillow, A...

jp-morgan-maintains-overweight-on-kenvue-raises-price-target-to-24
JP Morgan Maintains Overweight on Kenvue, ...
08/07/2024 17:40:24

JP Morgan analyst Andrea Teixeira maintains Kenvue (NYSE:KVUE) with a Overweight and raises the price target from $22 to $24.

deutsche-bank-maintains-buy-on-kenvue-raises-price-target-to-24
Deutsche Bank Maintains Buy on Kenvue, Rai...
08/07/2024 17:21:20

Deutsche Bank analyst Steve Powers maintains Kenvue (NYSE:KVUE) with a Buy and raises the price target from $23 to $24.

rbc-capital-reiterates-outperform-on-kenvue-maintains-24-price-target
RBC Capital Reiterates Outperform on Kenvu...
08/07/2024 17:16:24

RBC Capital analyst Nik Modi reiterates Kenvue (NYSE:KVUE) with a Outperform and maintains $24 price target.

decoding-5-analyst-evaluations-for-kenvue
Decoding 5 Analyst Evaluations For Kenvue
08/07/2024 15:01:18

ubs-maintains-neutral-on-kenvue-raises-price-target-to-22
UBS Maintains Neutral on Kenvue, Raises Pr...
08/07/2024 14:39:27

UBS analyst Peter Grom maintains Kenvue (NYSE:KVUE) with a Neutral and raises the price target from $20 to $22.

yum-china-posts-upbeat-earnings-joins-clear-secure-tg-therapeutics-bioventus-and-other-big-stocks-moving-higher-on-tuesday
Yum China Posts Upbeat Earnings, Joins Cle...
08/06/2024 15:47:18

listerine-maker-kenvues-stock-soars-on-strong-q2-sales-from-its-essential-health-unit-reaffirms-annual-guidance
Listerine-Maker Kenvue's Stock Soars On St...
08/06/2024 14:30:49

Kenvue sees stock rise following strong Q2 2024 results. Despite a slight dip in sales, revenue of $4 billion beat expectations...

kenvue-reaffirms-its-outlook-for-2024-including-net-sales-growth-of-10-30-20-40-organic-growth-and-adjusted-eps-of-110-120-versus-consensus-of-114
Kenvue Reaffirms Its Outlook For 2024, Inc...
08/06/2024 10:47:52

kenvue-q2-2024-adj-eps-032-beats-028-estimate-sales-4000b-beat-3942b-estimate
Kenvue Q2 2024 Adj. EPS $0.32 Beats $0.28 ...
08/06/2024 10:46:26

deutsche-bank-maintains-buy-on-kenvue-lowers-price-target-to-23
Deutsche Bank Maintains Buy on Kenvue, Low...
07/25/2024 16:11:04

Deutsche Bank analyst Steve Powers maintains Kenvue (NYSE:KVUE) with a Buy and lowers the price target from $24 to $23.

kenvue-boosts-quarterly-cash-dividend-by-25-from-020-to-0205-per-share
Kenvue Boosts Quarterly Cash Dividend By 2...
07/25/2024 10:59:45

The third quarter dividend is payable on August 28, 2024, to shareholders of record as of the close of business on August 14, 2...

kenvue-stock-a-deep-dive-into-analyst-perspectives-4-ratings
Kenvue Stock: A Deep Dive Into Analyst Per...
07/22/2024 16:00:22

jp-morgan-maintains-overweight-on-kenvue-lowers-price-target-to-22
JP Morgan Maintains Overweight on Kenvue, ...
07/22/2024 15:37:47

JP Morgan analyst Andrea Teixeira maintains Kenvue (NYSE:KVUE) with a Overweight and lowers the price target from $23 to $22.

citigroup-maintains-neutral-on-kenvue-lowers-price-target-to-20
Citigroup Maintains Neutral on Kenvue, Low...
07/11/2024 01:55:50

Citigroup analyst Filippo Falorni maintains Kenvue (NYSE:KVUE) with a Neutral and lowers the price target from $21 to $20.

sanofi-looks-to-sell-20b-icy-hot-division-likely-bidders-include-advent-pai-partners-blackstone-cvc
Sanofi Looks To Sell $20B Icy Hot Division...
06/26/2024 13:16:58

Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.

peering-into-kenvues-recent-short-interest
Peering Into Kenvue's Recent Short Interest
06/07/2024 15:15:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION